Endpoint Research is a full service Clinical Research Organization founded in 1990. We provide Phase I to IV clinical development services to pharmaceutical, biotechnology and medical device companies in most major therapeutic areas, with a strength in complex indications, particularly oncology and respiratory.
Endpoint has been an international CRO since 1998 when we opened our office in the United Kingdom. We have continued to expand our geographic reach and service offerings by opening our US office and implementing full, Oracle Clinical-based clinical data management, Medical and Consulting services.
Our head office is in Toronto, Canada with operational offices in Houston, Texas and Bells Hill, Scotland. Endpoint provides full clinical trial services (study design, management, monitoring, data handling and statistical services) for clinical trials in North America and Europe, including Eastern Europe.
Endpoint Research provides clinical research services from Phase I to regulatory submission. We have very strong capabilities in two therapeutic areas in particular:
